Phosphotyrosyl peptides and analogues as substrates and inhibitors of purple acid phosphatases

被引:49
作者
Valizadeh, M
Schenk, G
Nash, K
Oddie, GW
Guddat, LW
Hume, DA
de Jersey, J
Burke, TR
Hamilton, S [1 ]
机构
[1] Univ Queensland, Dept Biochem, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Dept Chem, St Lucia, Qld 4072, Australia
[3] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia
[4] NIH, Div Basic Sci, Med Chem Lab, Bethesda, MD 20892 USA
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
purple acid phosphatase; tartrate resistant acid phosphatase; inhibition and kinetic studies; phosphotyrosyl peptide; osteoporosis;
D O I
10.1016/j.abb.2004.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purple acid phosphatases are metal-containing hydrolases. While their precise biological role(s) is unknown, the mammalian enzyme has been linked in a variety of biological circumstances (e.g., osteoporosis) with increased bone resorption. Inhibition of the human enzyme is a possible strategy for the treatment of bone-resorptive diseases such as osteoporosis. Previously, we determined the crystal structure of pig purple acid phosphatase to 1.55 Angstrom and we showed that it is a good model for the human enzyme. Here, a study of the pH dependence of its kinetic parameters showed that the pig enzyme is most efficient at pH values similar to those encountered in the osteoclast resorptive space. Based on the observation that phosphotyrosine-containing peptides are good substrates for pig purple acid phosphatase, peptides containing a range of phosphotyrosine mimetics were synthesized. Kinetic analysis showed that they act as potent inhibitors of mammalian and plant purple acid phosphatases, with the best inhibitors exhibiting low micromolar inhibition constants at pH 3-5. These compounds are thus the most potent organic inhibitors yet reported for the purple acid phosphatases. (C) 2004 Published by Elsevier Inc.
引用
收藏
页码:154 / 162
页数:9
相关论文
共 46 条
[1]   Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover [J].
Angel, NZ ;
Walsh, N ;
Forwood, MR ;
Ostrowski, MC ;
Cassady, AI ;
Hume, DA .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :103-110
[2]   MECHANISM OF THE REACTION OF DIFFERENT PHOSPHATES WITH THE IRON(II)IRON(III) FORM OF PURPLE ACID-PHOSPHATASE FROM PORCINE UTERI (UTEROFERRIN) [J].
AQUINO, MAS ;
LIM, JS ;
SYKES, AG .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1994, (04) :429-436
[3]   SPECTROSCOPIC AND MAGNETIC STUDIES OF THE PURPLE ACID-PHOSPHATASE FROM BOVINE SPLEEN [J].
AVERILL, BA ;
DAVIS, JC ;
BURMAN, S ;
ZIRINO, T ;
SANDERSLOEHR, J ;
LOEHR, TM ;
SAGE, JT ;
DEBRUNNER, PG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (12) :3760-3767
[4]  
Baes C.F., 1976, HYDROLYSIS CATIONS
[5]   DERIVATIVES OF THE PURPLE PHOSPHATASE FROM RED KIDNEY BEAN - REPLACEMENT OF ZINC WITH OTHER DIVALENT METAL-IONS [J].
BECK, JL ;
MCARTHUR, MJ ;
DEJERSEY, J ;
ZERNER, B .
INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1988, 153 (01) :39-44
[6]   PROPERTIES OF A PURPLE PHOSPHATASE FROM RED KIDNEY BEAN - A ZINC-IRON METALLOENZYME [J].
BECK, JL ;
MCCONACHIE, LA ;
SUMMORS, AC ;
ARNOLD, WN ;
DEJERSEY, J ;
ZERNER, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 869 (01) :61-68
[7]   ENZYMATICALLY ACTIVE ZINC, COPPER AND MERCURY DERIVATIVES OF THE ONE-IRON FORM OF PIG ALLANTOIC FLUID ACID-PHOSPHATASE [J].
BECK, JL ;
KEOUGH, DT ;
DEJERSEY, J ;
ZERNER, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 791 (03) :357-363
[8]  
BURKE TR, 1991, SYNTHESIS-STUTTGART, P1019
[9]   SYNTHESIS OF 4-PHOSPHONO(DIFLUOROMETHYL)-D, L-PHENYLALANINE AND N-BOC AND N-FMOC DERIVATIVES SUITABLY PROTECTED FOR SOLID-PHASE SYNTHESIS OF NONHYDROLYZABLE PHOSPHOTYROSYL PEPTIDE ANALOGS [J].
BURKE, TR ;
SMYTH, MS ;
OTAKA, A ;
ROLLER, PP .
TETRAHEDRON LETTERS, 1993, 34 (26) :4125-4128
[10]   4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: A phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides [J].
Burke, TR ;
Ye, B ;
Akamatsu, M ;
Ford, H ;
Yan, XJ ;
Kole, HK ;
Wolf, G ;
Shoelson, SE ;
Roller, PP .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (05) :1021-1027